Long-Term Cost-utility Analysis of a Multidisciplinary Primary Care Diabetes Management Program in Ontario (Q57464659)

1

0 references

Robert Hopkins

2

0 references

Gordon Blackhouse

3

0 references

Philip Clarke

4

0 references

Janet Hux

5

0 references

Jean-Eric Tarride

6

0 references

Lisa Dolovich

7

0 references

Ron Goeree

Canadian Journal of Diabetes

8

0 references

publication date

January 2007

0 references

published in

0 references

volume

31

0 references

issue

3

0 references

page(s)

205-214

0 references

cites work

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Relation of glycemic control to diabetic complications and health outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

The cost of diabetes: time for a different approach?

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021

Probability of stroke: a risk profile from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-2671%2807%2913007-0

7 January 2021